Famous Israeli chemist, Raphael Mechoulam spent decades researching
the mysteries of marijuana in a lab, but his fascination with one of
the world's most popular drugs never led to personal experimentation.
In a recent interview with Culture Magazine, he said:
"I have never used it. First of all, I am still interested, but as I
did research and we had official supply of cannabis, obviously if we
had used it for non-scientific reasons, if people had come to know
about it that would have stopped our work.
Basically, neither I nor my students were interested."
His research into the pharmacology of cannabinoids (cannabis) began in
the early 1960s with a batch of hashish that police passed to him out
of an evidence locker.
Over the next few years, his group would become the first to isolate
and synthesize cannabidiol, or CBD, now revered for its potential
medical applications, as well as tetrahydrocannabinol, or THC, the
psychoactive compound in marijuana that makes users feel high.
Mechoulam's work also opened the door for more recent developments in
the field of marijuana medicine.
Studies have shown that cannabinoids have promise in the treatment of
ailments including cancer, epilepsy, chronic pain, anxiety and even
some psychotic symptoms.
0 Comments